Loading

Please wait...

Bevespi aerosphere

Generic Name: formoterol and glycopyrrolate (for MOE ter ol and GLYE koe PIR oh late)
Brand Names: Bevespi Aerosphere
Bevespi Aerosphere (formoterol and glycopyrrolate) is used to treat chronic obstructive pulmonary disease (COPD). Formoterol is a bronchodilator. Glycopyrrolate is an anticholinergic. These medications work by relaxing muscles in the airways to improve breathing.
  • Prescription Settings

Prices and coupons of Bevespi aerosphere

Current Location: 20149 (Ashburn)
Change Location?

Enter your zip code


Please wait while the prices are loaded...

Don’t see your pharmacy listed? Most pharmacies accept our discounts, so have your pharmacist enter this coupon to see if you will save money:

Drug Information:
Bevespi Aerosphere is an inhalation aerosol containing a combination of formoterol and glycopyrrolate. Formoterol is a bronchodilator. Glycopyrrolate is an anticholinergic. These medications work by relaxing muscles in the airways to improve breathing. Bevespi Aerosphere is used to prevent airflow obstruction or bronchospasm and reduce flare-ups in adults with COPD (chronic obstructive pulmonary disease), including bronchitis and emphysema. Bevespi Aerosphere is not for use in treating asthma. Formoterol may increase the risk of death in people with asthma, but the risk in people with COPD is not known. Talk with your doctor about your individual risk. Learn more

Bevespi aerosphere Side Effects

Bevespi Aerosphere Side Effects

Note: This document contains side effect information about formoterol / glycopyrrolate. Some of the dosage forms listed on this page may not apply to the brand name Bevespi Aerosphere.

For the Consumer

Applies to formoterol/glycopyrrolate: inhalation aerosol powder

Warning

Inhalation route (Aerosol Powder)

Glycopyrrolate and formoterol fumarate oral inhalation powder is not indicated for the treatment of asthma. Long-acting beta(2)-adrenergic agonists (LABAs), such as formoterol fumarate, increase the risk of asthma-related death.

Along with its needed effects, formoterol / glycopyrrolate may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking formoterol / glycopyrrolate:

Less common

  • Bladder pain
  • bloody or cloudy urine
  • chest pain
  • cough
  • difficult, burning, or painful urination
  • frequent urge to urinate
  • lower back or side pain

Incidence not known

  • Blindness
  • blurred vision
  • decrease in the frequency of urination
  • decrease in urine volume
  • decreased vision
  • difficulty with breathing
  • dizziness
  • eye pain
  • fainting
  • headache
  • hives or welts, itching, or skin rash
  • irregular heartbeat
  • nausea or vomiting
  • nervousness
  • noisy breathing
  • pounding in the ears
  • recurrent large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
  • redness of the skin
  • slow or fast heartbeat
  • tearing
  • tightness in the chest

Some side effects of formoterol / glycopyrrolate may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common

  • Difficulty with moving
  • dry mouth
  • fear
  • fever
  • muscle pain or stiffness
  • muscle spasm
  • pain in the arms or legs
  • pain in the joints
  • pain or tenderness around the eyes and cheekbones
  • sore throat
  • stuffy or runny nose
  • unusual tiredness or weakness

For Healthcare Professionals

Applies to formoterol / glycopyrrolate: inhalation aerosol

Respiratory

Common (1% to 10%): Cough (4%); In less than 2%: Chest pain, influenza, acute sinusitis

Cardiovascular

Frequency not reported: Formoterol fumarate: Palpitations, cardiac arrhythmias (atrial fibrillation, supraventricular tachycardia, extrasystoles)

Gastrointestinal

Common (1% to 10%): In less than 2%: Tooth abscess, oropharyngeal pain, vomiting, dry mouth

Frequency not reported: Formoterol fumarate: Nausea

Genitourinary

Common (1% to 10%): Urinary tract infection (2.6%)

Frequency not reported: Worsening of urinary retention

Hypersensitivity

Frequency not reported: Hypersensitivity reactions (formoterol fumarate)

Metabolic

Frequency not reported: Formoterol fumarate: Hyperglycemia

Musculoskeletal

Common (1% to 10%): In less than 2%: Arthralgia, muscle spasm, pain in the extremity

Nervous system

Common (1% to 10%): In less than 2%: Headache, dizziness

Frequency not reported: Formoterol fumarate: Tremor

Ocular

Frequency not reported: Worsening of narrow-angle glaucoma

Other

Common (1% to 10%): In less than 2%: Fall, fatigue, contusion

Psychiatric

Common (1% to 10%): Anxiety (less than 2%)

Frequency not reported: Paradoxical bronchospasm; Formoterol fumarate: Restlessness, sleep disturbances, agitation

Editorial References and Review

Medically reviewed by BestRx Medical Team Last updated on 1/1/2020.

Source: Drugs.com Bevespi Aerosphere